Loading...
(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) are a response to EGFR-tyrosine kinase inhibitor. However, a lack of sufficient tumor tissue has been a limitation for determining EGFR mutation status in clinical practice. The objective of this study was to pre...
Na minha lista:
| Udgivet i: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265876/ https://ncbi.nlm.nih.gov/pubmed/27472739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004421 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|